Melanocytic naevi of other and unspecified parts of face

CD2_BENIGN_MELANOCYTIC_FACE

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D22.3&
  • Hospital discharge: ICD-9 2163A
  • Cause of death: ICD-10 D22.3&
  • Cause of death: ICD-9 2163A

2 out of 7 registries used, show all original rules.

2330

4. Check minimum number of events

None

2330

5. Include endpoints

None

2330

6. Filter based on genotype QC (FinnGen only)

2330

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D22
Name in latin
Naevus melanocyticus (cutis) faciei

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 16215 10654 5504
Only index persons 15389 10225 5164
Unadjusted period prevalence (%)
Whole population 0.25 0.31 0.15
Only index persons 0.32 0.38 0.20
Median age at first event (years)
Whole population 44.36 44.13 44.75
Only index persons 44.23 43.97 44.75

-FinnGen-

Key figures

All Female Male
Number of individuals 2330 1635 695
Unadjusted period prevalence (%) 0.48 0.56 0.31
Median age at first event (years) 48.85 45.85 55.90

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2068
Matched controls
20680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
20.0
323.0
867
720
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
10681.7
323.0
1998
72
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.5
131.8
439
969
2163A
ICD-9 Finland
Benign neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]
+∞
77.6
74
*
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
8.8
74.1
165
201
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
9.7
68.4
144
159
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
5.0
68.2
236
520
L82
ICD-10 Finland
Seborrhoeic keratosis
2.8
53.8
403
1652
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
8.6
53.6
120
147
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.7
52.8
406
1688
L57.0
ICD-10 Finland
Actinic keratosis
3.6
51.8
260
804
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
4.4
51.3
197
480
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.8
50.6
234
675
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.9
44.6
197
545
TQW99
NOMESCO Finland
Other minor procedure on skin
4.4
41.7
160
388
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
3.9
36.2
158
431
QAE00
NOMESCO Finland
Excision of loose skin or fold of skin from head and neck
42.8
34.1
42
10
S82
ICPC
Naevus/mole
2.4
33.5
306
1374
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
5.1
31.1
101
206
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
4.5
26.2
96
223
9733
FHL
Excision of skin change in operating room or anesthesia
7.0
25.6
64
94
Z2221
NOMESCO Finland
Medical doctor
1.8
25.1
590
3825
S18
ICPC
Laceration/cut
1.7
25.0
804
5714
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
5.8
24.2
70
125
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
8.1
23.5
53
67
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.1
23.3
92
230
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
4.6
22.0
78
176
ZZR00
NOMESCO Finland
Flap of skin
5.2
21.9
69
137
DHB00
NOMESCO Finland
Excision of lesion of external nose
12.0
21.5
39
33
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.9
20.7
130
466
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
212.0
20.6
21
*
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
5.2
19.6
61
120
XQ848
NOMESCO Finland
Dermatological photography
4.0
19.4
78
199
SPAT1153
SPAT
Removal of sutures
1.6
19.3
586
4035
XQ845
NOMESCO Finland
Dermatoscopy
7.0
19.2
47
68
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
3.9
18.9
78
204
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
23.9
18.6
26
11
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
17.7
737
5459
ZXC50
NOMESCO Finland
Cryotherapy
3.9
17.6
74
197
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
5.7
17.5
50
89
D22
ICD-10 Finland
Melanocytic naevi
2.6
15.9
115
451
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
3.6
15.4
69
195
I78.1
ICD-10 Finland
Naevus, non-neoplastic
3.6
14.6
65
183
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
36.3
14.4
18
5
D22.0
ICD-10 Finland
Melanocytic naevi of lip
27.4
14.3
19
7
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
3.8
14.1
59
158
ZXA00
NOMESCO Finland
Right side
1.6
13.8
475
3326
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
13.6
662
5007
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
7.3
13.2
31
43
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
4.4
13.0
46
106
ZXE00
NOMESCO Finland
One hour or less
1.4
12.1
738
5796
ZXA05
NOMESCO Finland
Left side
1.5
12.1
433
3051
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
8.2
12.0
26
32
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
6.9
11.6
28
41
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
4.4
11.1
39
90
F16
ICPC
Eyelid symptom/complaint
2.3
11.0
97
426
S21
ICPC
Skin texture symptom/complaint
1.7
10.8
218
1319
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
10.6
661
5183
J01DB01
ATC
cefalexin; oral
1.4
10.6
1584
14407
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
3.4
10.4
48
142
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
32.7
10.3
13
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
10.1
373
2638
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
40.2
10.0
12
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
9.9
426
3105
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
6.3
9.8
25
40
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
10.7
9.8
18
17
D22.1
ICD-10 Finland
Melanocytic naevi of eyelid, including canthus
7.8
9.6
21
27
ZXD20
NOMESCO Finland
Day surgery
1.6
9.5
238
1531
S29
ICPC
Skin symptom/complaint other
1.6
9.4
294
1996
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
3.0
9.3
51
172
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
8.7
9.3
19
22
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
5.5
9.2
26
48
A02BC02
ATC
pantoprazole; systemic
1.3
9.0
1155
10085
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
36.8
9.0
11
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
8.7
304
2120
E0000UV
ATC
NA
1.3
8.7
715
5833
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
3.6
8.6
37
104
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
5.3
8.6
25
48
K03.64
ICD-10 Finland
Dental calculus supragingival
1.4
8.6
520
4035
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
4.4
8.5
29
66
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
2.6
8.5
61
241
WX110
NOMESCO Finland
Local anesthesy
1.3
8.4
1308
11693
DAB00
NOMESCO Finland
Excision of lesion of auricle
5.0
8.3
25
50
L72.1
ICD-10 Finland
Trichilemmal cyst
1.9
8.3
112
592
J01FA10
ATC
azithromycin; systemic
1.3
8.3
1116
9758
Z3231
NOMESCO Finland
Registered nurse
1.4
8.3
461
3518
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
22.1
8.0
11
5
ZXC20
NOMESCO Finland
Use of chemical agents
3.3
7.9
38
118
ZXA10
NOMESCO Finland
Bilateral
1.5
7.9
309
2205
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
7.9
1339
12062
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
3.5
7.9
34
97
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
7.6
217
1441
S04
ICPC
Lump/swelling localized
1.7
7.5
156
953
Z01.7
ICD-10 Finland
Laboratory examination
1.6
7.5
195
1264
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
6.5
7.4
18
28
L04AA01
ATC
[U] ciclosporin; systemic
3.5
7.4
32
92
Z94.0
ICD-10 Finland
Kidney transplant status
4.1
7.4
27
67
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.2
409
3121
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
4.3
7.2
25
59
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
4.8
7.1
22
46
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
3.4
7.1
32
95
ZQZ00
NOMESCO Finland
Treatment of several skin areas
7.0
7.0
16
23
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
6.9
679
5642
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
6.9
390
2977
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
6.8
261
1848
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
6.8
152
951
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
4.1
6.7
24
59
A98
ICPC
Health maint/preventive medicine
1.6
6.7
1947
18790
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
6.7
256
1817
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
4.9
6.7
20
41
R74
ICPC
Upper respiratory infection acute
1.3
6.7
537
4332
CBB30
NOMESCO Finland
Excision of lesion of eyelid
2.4
6.6
53
223
EMB10
NOMESCO Finland
Tonsillectomy
1.8
6.6
115
670
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
6.6
928
8069
127
Kela drug reimbursment
Transplant complication
3.2
6.5
32
102
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.4
6.5
422
3288
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
10.0
6.5
12
12
J05AB11
ATC
valaciclovir; oral
1.5
6.5
221
1527
J02AC01
ATC
fluconazole; systemic
1.3
6.5
757
6417
CBA10
NOMESCO Finland
Biopsy of eyelid
5.3
6.5
18
34
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
4.4
6.3
21
48
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
4.4
6.3
21
48
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
5.2
6.3
18
35
-
ICD-10 Finland
NA
2.5
6.3
45
181
C43.33
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face nodular
+∞
6.3
6
*
D03.30
ICD-10 Finland
Melanoma in situ on the lip
26.7
6.2
8
*
A02BC05
ATC
esomeprazole; systemic
1.3
6.2
686
5767
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
2.5
6.2
44
175
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
6.2
146
925
J01MA02
ATC
ciprofloxacin; systemic
1.3
6.1
621
5160
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
7.7
6.1
13
17
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
3.7
6.1
24
65
WX002
NOMESCO Finland
Sedation and analgesia
1.4
6.0
310
2323
R4110
NOMESCO Finland
Physiotherapy
1.3
6.0
430
3399
L91.0
ICD-10 Finland
Hypertrophic scar
3.0
6.0
32
109

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
1246
7845
2.26
80.03
2.7
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
444
2389
2.06
37.27
1.4
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1857
16831
1.51
13.88
18.8
16.4
g/l
332.1
332.3
0.44
1840
16708
(3006315) Basophils [#/volume] in Blood
1142
9614
1.37
12.24
6.0
5.7
e9/l
0.0
0.0
0.97
991
8378
(3001604) Monocytes [#/volume] in Blood
1138
9578
1.37
12.20
6.0
5.7
e9/l
0.6
0.6
1.10
988
8347
(3033658) Prothrombin time (PT) actual/Normal
614
4670
1.43
12.06
4.2
3.7
%
92.2
92.7
0.21
600
4537
(3013115) Eosinophils [#/volume] in Blood
1174
9951
1.36
11.93
6.3
6.0
e9/l
0.2
0.2
0.12
1031
8816
(3013650) Neutrophils [#/volume] in Blood by Automated count
1285
11100
1.35
11.27
9.0
8.8
e9/l
3.8
4.0
2.95
1111
9763
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
458
3339
1.46
11.19
3.1
3.5
ng/l
247.0
452.1
0.75
313
2389
(3019550) Sodium [Moles/volume] in Serum or Plasma
2078
19509
1.60
11.16
15.6
14.3
mmol/l
139.7
139.6
1.00
2036
18995
(3023103) Potassium [Moles/volume] in Serum or Plasma
2081
19565
1.60
10.85
15.8
14.4
mmol/l
3.9
3.9
3.74
2036
19016
(3019198) Lymphocytes [#/volume] in Blood
1158
9889
1.34
10.75
6.0
5.7
e9/l
2.0
1.9
0.67
1027
8794
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1976
18387
1.49
10.64
4.5
4.2
mmol/l
5.8
5.8
0.77
1847
16884
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1938
17973
1.47
10.53
5.6
4.8
mu/l
1.8
2.0
0.86
1825
16652
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2064
19394
1.56
10.50
13.9
12.9
mg/l
21.6
22.1
0.26
1627
15229
(42870588) Differential panel, method unspecified - Blood
787
6359
1.36
10.48
6.0
5.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1603
14404
1.36
10.42
7.9
7.2
u/l
76.7
76.6
0.04
1504
13571
(3002582) Erythrocytes [#/volume] in Urine
689
5472
1.37
10.18
3.2
3.1
e6/l
29.4
88.4
2.36
524
4171
(3010813) Leukocytes [#/volume] in Blood
2251
21696
2.11
9.94
21.3
19.0
e9/l
6.6
6.7
0.37
2200
21131
(3035941) MCH [Entitic mass]
2250
21689
2.09
9.84
21.2
18.9
pg
30.1
30.2
0.97
2228
21412
(3013707) Erythrocyte sedimentation rate by Westergren method
1581
14227
1.35
9.83
4.2
4.0
mm/h
10.6
11.4
2.02
1476
13202
(3018095) Leukocytes [#/volume] in Urine
804
6566
1.34
9.83
3.8
3.5
e6/l
49.0
100.6
2.51
560
4524
(3026361) Erythrocytes [#/volume] in Blood
2250
21691
2.09
9.80
21.3
19.0
e12/l
4.5
4.5
1.62
2199
21136
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2147
20418
1.66
9.73
16.0
14.7
umol/l
73.7
73.6
0.05
2147
20410
(3000963) Hemoglobin [Mass/volume] in Blood
2250
21701
2.07
9.62
21.4
19.1
g/l
135.0
134.7
0.40
2226
21424
(3024731) MCV [Entitic volume]
2249
21688
2.06
9.62
21.3
18.9
fl
90.5
90.7
1.47
2227
21414
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1855
17154
1.40
9.46
5.6
5.3
mmol/mol
38.6
39.1
2.31
1761
15977
(40758558) Short blood count panel - Blood
613
4833
1.36
9.35
6.7
6.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
411
3040
1.43
9.14
2.7
2.6
e6/l
0.9
1.1
0.77
224
1694
(3007853) Bacteria identified in Skin by Aerobe culture
314
2208
1.49
9.09
1.5
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2244
21675
1.96
8.73
21.4
19.0
e9/l
256.7
256.8
0.03
2199
21165
(3006504) Eosinophils/100 leukocytes in Blood
1051
9019
1.30
8.73
6.1
5.8
%
2.8
2.8
0.05
982
8413
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
301
2116
1.49
8.72
2.9
2.6
umol/l
7.9
7.2
0.21
258
1824
(3022096) Basophils/100 leukocytes in Blood
1020
8741
1.30
8.47
6.2
5.8
%
0.7
0.7
0.01
955
8164
(3044889) 12 lead EKG panel
1447
12981
1.30
8.46
3.8
3.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2030
19168
1.46
8.40
5.0
4.5
mmol/l
2.8
2.8
0.21
1912
17795
(3019069) Monocytes/100 leukocytes in Blood
1053
9069
1.29
8.39
6.3
6.0
%
8.4
8.4
0.05
992
8508
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1682
15412
1.33
8.38
4.8
4.1
pmol/l
14.6
14.7
0.68
1558
14163
(3024561) Albumin [Mass/volume] in Serum or Plasma
919
7776
1.30
8.38
4.7
4.6
g/l
36.3
35.9
1.55
856
7245
(3037467) Urinalysis macro (dipstick) panel - Urine
1471
13253
1.30
8.18
4.8
4.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
622
5005
1.33
8.10
3.1
3.0
e6/l
0.4
0.4
0.01
448
3750
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
381
2846
1.40
7.94
2.7
2.7
e6/l
3.9
3.0
0.61
197
1510
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1037
8965
1.28
7.84
6.7
6.3
mmol/l
1.2
1.2
0.08
905
7575
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1990
18770
1.41
7.82
4.3
4.1
mmol/l
1.5
1.5
0.20
1863
17450
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
864
7308
1.29
7.73
2.0
1.9
pmol/l
100.8
96.2
1.90
433
3786
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1494
13542
1.29
7.63
3.6
3.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1998
18882
1.41
7.55
4.4
4.1
mmol/l
4.7
4.7
0.41
1888
17662
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1093
9543
1.27
7.52
6.2
5.9
umol/l
10.9
10.9
0.01
1029
9040
(3031040) Bacteria [#/volume] in Urine by Automated count
1408
12687
1.28
7.44
4.9
4.3
e6/l
376.4
1998.7
1.77
16
168
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2141
20512
1.54
7.43
10.9
9.8
u/l
26.1
25.5
0.58
2083
19862
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
761
6358
1.29
7.41
3.4
3.1
u/l
30.6
31.8
0.40
722
6058
(3010375) cycloSPORINE [Mass/volume] in Blood
25
73
3.45
7.39
34.0
28.0
ug/l
83.3
122.2
4.78
25
63
(40761511) CBC panel - Blood by Automated count
2126
20343
1.51
7.36
12.7
12.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
249
1745
1.48
7.31
2.4
2.3
u/l
33.6
65.6
0.61
207
1486
(3000494) Fungus identified in Specimen by Culture
299
2171
1.43
7.29
1.4
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1072
9361
1.27
7.28
6.2
5.8
%
29.3
28.6
1.26
1007
8748
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1921
18063
1.36
7.27
3.9
3.7
mmol/l
1.3
1.3
0.56
1788
16702
(3018010) Neutrophils/100 leukocytes in Blood
1057
9237
1.26
7.05
6.0
5.6
%
56.1
56.9
1.40
994
8666
(3002385) Erythrocyte distribution width [Ratio]
1766
16434
1.31
6.97
17.7
15.6
%
13.5
13.6
1.18
1736
16083
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
195
1328
1.51
6.59
3.7
3.3
pmol/l
4.5
4.5
0.01
172
1182
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
514
4134
1.31
6.54
1.7
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
643
5339
1.28
6.40
4.6
3.8
ph
7.4
7.4
0.46
78
1009
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
417
3268
1.34
6.35
2.9
2.9
mmol/l
2.4
2.4
0.51
347
2880
(3011397) Hemoglobin [Presence] in Urine by Test strip
539
4379
1.30
6.34
4.1
3.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
923
8014
1.25
6.28
2.4
2.3
nmol/l
76.7
76.6
0.05
851
7292
(36304419) Bacteria [Presence] in Urine
597
4923
1.29
6.25
3.1
2.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
933
8122
1.25
6.17
6.0
5.6
mmol/l
1.2
1.2
0.05
858
7373
(3015377) Calcium [Moles/volume] in Serum or Plasma
734
6227
1.26
6.06
3.3
3.3
mmol/l
2.4
2.4
0.14
633
5501
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
195
1353
1.48
6.03
4.5
3.6
ng/l
82.8
84.5
0.11
181
1181
(3026008) Bacteria identified in Urine by Culture
679
5733
1.26
5.79
3.1
2.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1916
18166
1.31
5.67
16.2
13.8
%
40.1
39.8
1.07
1480
13635
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
388
3070
1.32
5.48
4.6
4.1
%
22.4
21.3
0.63
177
1411
(3009261) Glucose [Presence] in Urine by Test strip
1074
9595
1.22
5.30
3.9
3.5
estimate
0.0
0.0
1.32
166
1769
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
590
4946
1.26
5.28
1.7
1.6
mmol/l
1.4
1.4
0.04
533
4193
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
19
59
3.24
5.17
2.0
3.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
272
2068
1.36
5.03
1.3
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
561
4701
1.25
5.00
2.6
2.5
umol/l
2548.4
5168.0
1.35
494
4132
(3013826) Glucose [Moles/volume] in Serum or Plasma
1189
10769
1.21
5.00
4.3
4.5
mmol/l
6.5
6.6
1.07
1098
9989
(3000850) Epithelial cells [#/volume] in Urine
465
3818
1.27
4.92
2.7
2.5
e6/l
4.4
6.7
3.50
401
3345
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
465
3826
1.27
4.83
5.4
4.8
ug/l
2.3
2.6
0.47
412
3410
(3000492) Spirometry study
249
1886
1.36
4.72
1.5
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
93
581
1.63
4.65
1.2
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
623
5319
1.23
4.65
2.0
2.1
u/l
139.8
208.6
2.54
590
5027
(40768443) Skin Pathology biopsy report
119
789
1.54
4.62
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
321
2536
1.31
4.57
2.3
2.3
ug/g
82.8
117.1
3.07
249
2002
(3015736) pH of Urine
833
7338
1.21
4.54
3.7
3.3
—
5.9
—
0
6
(3021601) Nitrite [Presence] in Urine by Test strip
1054
9497
1.20
4.51
5.1
4.8
estimate
0.0
0.0
0.50
169
1810
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
92
579
1.61
4.48
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
93
589
1.60
4.42
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
286
2242
1.31
4.30
3.0
2.9
ug/l
0.7
0.7
0.24
183
1430
(3003458) Phosphate [Moles/volume] in Serum or Plasma
286
2243
1.31
4.29
5.4
5.4
mmol/l
1.1
1.0
0.71
268
2081
(3035350) Ketones [Presence] in Urine by Test strip
1047
9473
1.19
4.16
3.9
3.5
estimate
0.0
0.0
0.50
162
1780
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1011
9125
1.19
4.12
4.2
4.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1002
9037
1.19
4.12
3.2
2.8
ug/l
101.2
103.2
0.07
949
8402
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1887
18035
1.24
4.09
13.1
11.7
ml/min/173m2
84.6
84.3
0.25
1533
14815
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
196
1468
1.37
4.02
2.5
2.5
ml/min/173m2
66.0
69.6
0.55
77
574
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
161
1168
1.41
4.00
2.4
3.2
u/ml
85.0
46.3
0.55
155
1130
(40768797) Stomach Pathology biopsy report
324
2624
1.27
3.80
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
629
5471
1.21
3.79
3.2
3.2
mmol/l
7.7
7.5
0.63
550
4641
(3002173) Hemoglobin [Mass/volume] in Arterial blood
205
1564
1.34
3.74
6.0
8.3
g/l
124.2
121.5
1.18
195
1507
(3030981) Hyaline casts [#/volume] in Urine by Automated count
126
892
1.44
3.61
2.8
2.7
e6/l
0.1
0.3
2.53
120
861
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1400
13082
1.18
3.56
3.1
3.0
u/l
47.6
43.4
0.61
1320
12298
(3017446) Testosterone [Moles/volume] in Serum or Plasma
143
1040
1.40
3.53
2.5
2.1
nmol/l
11.6
12.2
0.37
135
919
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
125
889
1.43
3.50
7.1
10.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
87
576
1.53
3.48
1.5
1.3
u/l
8.5
11.1
1.49
71
465
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
87
576
1.53
3.48
1.3
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
202
1558
1.32
3.44
1.3
1.2
iu/ml
123.3
150.0
0.51
80
603
(3049717) Cytology report of Urine Cyto stain
88
586
1.52
3.43
2.3
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
343
2835
1.25
3.39
3.2
3.2
mmol/l
0.8
0.8
0.03
321
2659
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
223
1750
1.30
3.36
1.9
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
239
1895
1.29
3.33
5.5
7.6
mmol/l
0.8
1.1
0.49
177
1467
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
181
1384
1.33
3.28
1.8
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
330
2727
1.24
3.27
1.4
1.3
titre
734.2
503.0
0.72
73
561
(3011325) HIV 1+2 Ab [Presence] in Serum
6
7
8.59
3.26
1.2
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
593
5196
1.19
3.24
3.8
3.9
mg/mmol
12.9
8.7
0.64
368
3246
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
19
4.75
3.23
1.1
2.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
106
743
1.45
3.23
1.4
1.3
miu/ml
240.1
229.0
0.11
49
358
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
26
123
2.13
3.20
6.4
6.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
54
327
1.67
3.15
1.3
1.4
ug/l
3.0
4.3
0.78
45
301
(3022689) Creatine [Moles/volume] in Urine
13
44
2.97
3.13
1.2
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
44
2.97
3.13
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
563
4934
1.19
3.05
3.3
3.2
mg/l
198.2
353.3
0.53
366
3072
(3019150) Specific gravity of Urine by Refractometry
480
4150
1.20
3.03
4.5
3.9
kg/l
1.0
1.0
0.17
62
606
(1002224) Polysomnography panel
117
847
1.40
3.01
1.1
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
496
4308
1.19
2.97
2.0
1.7
mg/l
1.1
1.1
0.14
377
3254
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
236
1900
1.27
2.93
5.6
7.5
kpa
5.1
5.1
0.27
224
1818
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
236
1903
1.27
2.90
4.5
4.0
u/l
230.0
249.3
1.24
220
1794
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
337
2830
1.22
2.87
1.7
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
397
3393
1.20
2.83
1.3
1.3
u/ml
5.1
10.6
1.93
143
1368
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
45
268
1.69
2.82
1.7
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
150
1143
1.33
2.82
1.3
1.3
iu/l
24.8
28.3
0.64
135
972
(3027801) Oxygen [Partial pressure] in Arterial blood
235
1901
1.26
2.82
5.6
7.5
kpa
12.7
12.7
0.02
223
1820
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
36
202
1.79
2.77
5.3
4.4
u/ml
273.1
98.6
0.34
11
53
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
529
4653
1.18
2.72
1.3
1.3
u/ml
0.7
1.5
3.76
122
1251
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
45
271
1.67
2.72
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
47
287
1.65
2.70
1.3
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
115
849
1.37
2.67
1.5
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
79
546
1.46
2.65
2.0
1.9
iu/l
2.8
5.0
2.42
22
202
(3018677) aPTT in Platelet poor plasma by Coagulation assay
319
2692
1.21
2.60
2.6
2.0
s
30.1
29.5
0.71
308
2603
(3016502) Oxygen saturation in Arterial blood
208
1676
1.26
2.59
5.9
8.1
%
95.9
95.8
0.17
196
1621
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
453
3954
1.18
2.55
1.5
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
40
238
1.69
2.55
1.6
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
78
543
1.45
2.53
4.5
7.3
mmol/l
1.1
1.3
0.79
68
473
(3044640) Blood type and Crossmatch panel - Blood
670
6034
1.15
2.52
2.4
2.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
457
4000
1.18
2.49
1.5
1.4
g/l
2.1
2.3
2.30
268
2494
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
11
39
2.83
2.47
1.2
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
107
792
1.37
2.46
1.3
1.3
u/ml
1.3
1.1
0.05
12
61
(3004716) Salmonella sp identified in Stool by Organism specific culture
147
1143
1.31
2.43
1.4
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
76
531
1.45
2.43
2.5
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
238
1963
1.24
2.43
1.6
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
759
6913
1.15
2.42
7.2
8.3
inr
1.2
1.2
0.83
193
2062
(3025018) Bordetella pertussis Ab [Titer] in Serum
23
117
1.98
2.40
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
32
182
1.77
2.40
1.1
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
27
3.34
2.39
1.3
1.3
ng/l
127.2
84.1
—
9
27
(3030313) Adrenal Ab [Titer] in Serum
7
17
4.13
2.36
1.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
173
1381
1.27
2.35
7.9
8.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
235
1948
1.23
2.30
1.6
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
483
4273
1.16
2.29
2.0
1.9
—
—
—
0
0
(4010399)
162
1288
1.28
2.28
1.5
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
122
935
1.32
2.26
2.5
2.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
404
3535
1.17
2.21
1.3
1.3
iu/ml
33.3
30.6
0.09
109
1114
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
638
5782
1.14
2.16
2.5
2.5
u/l
54.3
56.9
1.36
587
5355
(4211845)
19
94
2.03
2.16
3.3
2.9
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
76
545
1.41
2.15
3.9
2.6
g/l
3.7
3.6
0.44
70
514
(3045414) Leukocytes [Presence] in Urine
115
882
1.32
2.14
2.2
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
77
555
1.40
2.12
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
36
221
1.64
2.09
1.3
1.4
—
—
—
0
0
(3039000) Anion gap in Blood
56
382
1.48
2.07
5.0
8.8
mmol/l
10.6
11.3
0.89
49
346
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
132
1038
1.29
2.05
2.1
2.2
u/l
4327.9
5770.4
0.23
53
421
(3018572) Chloride [Moles/volume] in Blood
56
383
1.47
2.04
5.0
8.8
mmol/l
105.0
105.2
0.18
49
347
(3021589) Normoblasts [#/volume] in Blood
917
8528
1.12
2.04
8.8
8.9
e9/l
0.0
0.0
0.01
728
6996
(3020779) Urea [Moles/volume] in Serum or Plasma
175
1426
1.25
2.03
6.9
7.2
mmol/l
10.1
9.1
0.87
161
1365
(3027945) Reticulocytes/100 erythrocytes in Blood
223
1867
1.22
2.01
2.7
2.7
%
1.7
1.8
0.70
201
1660
(3051387) C reactive protein [Mass/volume] in Capillary blood
23
402
0.57
2.00
3.9
3.7
mg/l
43.5
24.7
0.68
16
261
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
39
251
1.56
1.90
1.3
1.3
nmol/l
—
0.4
—
0
15
(3038177) Helicobacter pylori Ab [Presence] in Serum
50
340
1.48
1.90
1.2
1.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
18
92
1.96
1.90
2.4
2.3
ug/l
18.9
105.0
0.49
18
81
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
207
1734
1.21
1.87
3.3
4.1
ug/l
28.9
21.5
0.12
156
1383
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
111
866
1.30
1.86
6.9
9.4
mmol/l
24.0
24.3
0.50
102
813
(3000034) Microalbumin [Mass/volume] in Urine
27
159
1.71
1.85
2.5
3.1
mg/l
17.8
38.9
0.73
21
112
(3021960) Folate [Moles/volume] in Serum or Plasma
458
4101
1.15
1.84
1.6
1.5
nmol/l
20.9
20.9
0.01
405
3523
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
52
359
1.46
1.84
1.5
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
78
580
1.36
1.82
2.0
1.6
g/l
0.2
0.2
0.53
73
549
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
23
130
1.78
1.81
1.0
1.1
iu/ml
2.0
11.1
—
8
36
(3022217) INR in Platelet poor plasma by Coagulation assay
243
2073
1.19
1.81
22.6
22.7
inr
1.2
1.3
0.31
38
297
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
117
1470
0.79
1.80
2.9
3.4
mmol/l
1.2
1.2
0.36
101
1263
(3009466) Valproate [Moles/volume] in Serum or Plasma
15
287
0.52
1.79
6.8
5.5
umol/l
412.3
368.2
0.69
15
247
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
146
1.72
1.77
1.2
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
9
36
2.51
1.74
1.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
36
2.51
1.74
1.2
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
163
1345
1.23
1.72
2.7
2.8
ng/l
103.2
181.8
6.37
147
1214
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
30
186
1.62
1.72
3.5
3.0
nmol/l
2.4
32.9
0.52
30
181
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
78
589
1.34
1.67
3.0
3.6
u/ml
321.8
2337.6
0.63
63
507
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
21
119
1.77
1.66
2.7
2.1
e9/l
0.2
0.2
0.64
16
104
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
43
293
1.48
1.65
1.4
1.4
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
20
112
1.79
1.64
1.5
1.3
umol/l
5.5
5.3
0.10
20
107
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
163
1355
1.22
1.62
2.4
2.4
au/ml
40.1
21.5
—
9
86
(3005322) IgE [Units/volume] in Serum or Plasma
160
1328
1.22
1.61
1.3
1.3
u/ml
166.3
198.1
0.40
155
1220
(3025130) Human papilloma virus identified in Specimen
47
328
1.44
1.61
1.7
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
503
4572
1.13
1.60
2.5
2.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
23
136
1.70
1.59
1.2
1.3
—
—
—
0
0
(3026782) Osmolality of Urine
398
3571
1.14
1.56
2.7
2.6
mosm/kgh2o
536.3
541.8
0.20
347
3039
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
35
232
1.52
1.54
1.3
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
187
2197
0.84
1.54
4.2
4.2
%
33.5
32.5
0.65
128
1541
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
21
123
1.71
1.51
2.7
2.1
e6/l
480.3
575.0
0.35
16
104
(3006462) Nitrate [Presence] in Urine
16
86
1.87
1.50
3.7
3.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
51
367
1.40
1.49
1.1
1.1
u/ml
2.8
2.9
0.00
17
91
(3025941) Bacteria identified in Stool by Culture
138
1142
1.22
1.46
1.4
1.2
—
—
—
0
0
(3010421) pH of Blood
31
462
0.67
1.45
3.5
3.7
ph
7.4
7.4
0.66
31
370
(3000060) B lymphocytes [#/volume] in Blood
11
52
2.12
1.44
1.5
1.9
e6/l
146.0
167.7
—
5
26
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
60
447
1.35
1.44
1.2
1.1
u/ml
0.7
1.5
0.82
30
174
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
61
456
1.35
1.43
1.1
1.2
—
6.2
—
0
8
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
13
66
1.98
1.43
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
26
164
1.59
1.43
3.3
3.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
100
801
1.26
1.42
1.8
2.0
u/l
38.6
39.3
0.18
90
725
(3026389) Candida sp identified in Specimen by Organism specific culture
39
270
1.45
1.42
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
149
1.62
1.41
1.3
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
43
304
1.42
1.40
1.9
1.5
g/l
0.9
0.7
0.29
37
228
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
92
731
1.27
1.40
1.9
1.9
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
52
381
1.37
1.39
1.2
1.1
u/ml
0.9
1.5
0.38
29
157
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
33
222
1.49
1.38
1.3
1.3
nmol/l
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
11
53
2.08
1.38
1.2
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
152
1278
1.20
1.38
1.6
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
292
2591
1.15
1.37
2.8
2.3
g/l
2.4
2.4
0.44
276
2396
(3013139) Helicobacter pylori Ag [Presence] in Stool
151
1272
1.20
1.35
1.3
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
326
2917
1.14
1.35
2.0
2.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
237
2074
1.16
1.35
6.3
6.5
mmol/l
104.7
104.4
0.43
232
2028
(36660697) Celiac disease serology panel - Serum
191
1645
1.18
1.33
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
53
393
1.36
1.33
1.2
1.1
u/ml
7.0
5.3
0.29
36
204
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
12
61
1.97
1.32
1.3
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
293
2609
1.14
1.31
2.0
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
275
2439
1.14
1.30
1.8
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
164
1398
1.19
1.29
2.0
2.3
ug/l
5.0
6.8
1.06
136
1233
(3036481) Cortisol [Moles/volume] in Serum or Plasma
207
1799
1.17
1.29
2.3
2.1
nmol/l
378.1
377.4
0.02
191
1650
(3023520) Reticulocytes [#/volume] in Blood
160
1363
1.19
1.28
2.7
2.6
e9/l
68.4
71.2
0.42
119
1029
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
32
220
1.46
1.23
1.4
1.4
pmol/l
311.4
291.3
0.21
25
171
(4268621)
32
220
1.46
1.23
2.4
2.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
131
1.61
1.23
1.5
2.0
%
10.1
13.6
1.24
12
66
(3019060) Gas panel - Arterial blood
128
1074
1.20
1.21
3.8
5.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
485
4470
1.11
1.21
3.8
4.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
5
19
2.63
1.21
1.4
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
37
2.17
1.21
1.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
104
856
1.22
1.20
1.9
1.6
mu/l
317.2
301.6
0.21
96
768
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
23
148
1.56
1.20
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
81
649
1.26
1.19
1.6
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
86
1.75
1.19
1.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
38
2.11
1.18
1.0
1.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
34
239
1.43
1.18
1.7
1.5
mu/l
21.8
45.7
1.84
29
216
(3008152) Bicarbonate [Moles/volume] in Arterial blood
124
1041
1.20
1.18
5.3
7.3
mmol/l
24.7
24.5
0.24
114
973
(3045424) Erythrocytes [Presence] in Urine
44
324
1.36
1.18
1.5
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
123
1032
1.20
1.18
7.0
9.0
%
94.1
94.0
0.09
123
1026
(3045683) HLA typing for celiac disease panel - Blood or Tissue
20
125
1.61
1.17
1.1
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
131
1106
1.20
1.17
1.1
1.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
70
552
1.28
1.17
6.8
2.5
%
182.3
179.9
0.08
64
530
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
51
385
1.33
1.17
1.5
1.5
nmol/l
0.3
0.4
0.23
43
301
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
82
660
1.25
1.16
1.8
1.8
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
36
0.00
1.14
0.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
43
318
1.36
1.13
1.1
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
123
1037
1.20
1.13
6.9
8.9
%
0.7
0.7
0.27
123
1031
(3011412) CD3 cells [#/volume] in Blood
25
167
1.50
1.12
2.6
2.1
e9/l
1.2
1.2
—
10
102
(3047007) Chlamydophila sp Ab [Presence] in Serum
42
310
1.36
1.12
1.2
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
40
2.00
1.12
1.4
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
40
2.00
1.12
1.4
1.2
%
91.3
93.7
—
8
40
(4062490)
28
192
1.46
1.11
1.4
1.4
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
13
73
1.79
1.10
1.5
2.0
%
6.5
10.9
1.12
13
68
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
37
268
1.39
1.10
1.1
1.0
u/ml
0.8
0.4
0.25
12
61
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
7
31
2.26
1.10
1.9
1.2
nmol/l
5.3
5.7
—
7
31
(3008536) Aspergillus sp Ab [Presence] in Serum
7
31
2.26
1.10
1.1
1.2
—
—
—
0
0
(4094501)
60
469
1.29
1.09
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
21
2.38
1.09
1.0
2.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
23
152
1.52
1.09
1.7
1.5
g/l
0.8
1.0
2.05
23
152
(3022948) Iron [Moles/volume] in Serum or Plasma
312
2826
1.12
1.09
2.8
2.3
umol/l
76.8
13.5
0.49
299
2610
(3023368) Bacteria identified in Blood by Culture
497
4613
1.10
1.08
4.2
4.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
59
749
0.78
1.08
3.9
3.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
48
365
1.32
1.07
5.6
2.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
148
1276
1.17
1.06
3.0
2.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
352
3846
0.90
1.06
1.6
1.6
pmol/l
431.5
29273275.7
3.29
302
3218
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
259
2325
1.13
1.05
1.7
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
48
366
1.32
1.05
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
48
366
1.32
1.05
1.3
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
39
289
1.36
1.03
1.1
1.1
u/ml
5.3
5.9
0.07
20
116
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
89
735
1.22
1.03
2.4
1.9
g/l
1.2
1.5
2.51
75
642
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
274
0.65
1.00
1.1
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
149
1293
1.16
1.00
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
93
775
1.21
0.99
1.8
1.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
32
436
0.73
0.99
4.0
4.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
23
2.18
0.98
1.6
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
130
1118
1.17
0.98
2.0
1.8
g/l
1.9
1.4
0.50
118
1027
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
29
0.00
0.97
0.0
1.1
—
1.7
—
0
18
(3011648) Oxygen content in Venous blood
21
140
1.50
0.97
2.4
1.9
%
12.3
11.1
0.72
21
140
(3004775) Volume in Urine collected for unspecified duration
20
132
1.52
0.97
2.5
2.3
ml
693.9
629.9
0.37
15
88
(4035726)
183
1617
1.14
0.96
1.3
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
235
0.64
0.96
1.1
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
237
2131
1.12
0.95
8.0
6.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
32
0.00
0.95
0.0
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
162
1841
0.87
0.95
3.0
3.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
51
1.77
0.94
4.4
2.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
45
578
0.77
0.94
1.4
1.5
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
284
2584
1.11
0.93
2.0
2.0
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
45
347
1.30
0.93
1.5
1.4
u/l
19.1
25.6
0.87
38
289
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
12
70
1.72
0.92
2.7
2.1
ug/l
1.4
1.2
0.24
12
65
(3000093) Morphology [Interpretation] in Blood Narrative
21
142
1.48
0.92
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
28
2.15
0.91
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
28
2.15
0.91
4.0
5.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
48
376
1.28
0.90
1.5
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
21
143
1.47
0.89
1.9
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
263
2392
1.11
0.88
3.0
2.4
%
22.5
23.2
0.37
222
2046
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
11
64
1.72
0.86
2.4
4.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
120
1042
1.16
0.83
7.1
8.8
%
1.3
1.4
0.10
120
1036
(3028192) IgG subclass 2 [Mass/volume] in Serum
26
188
1.39
0.83
1.3
1.4
g/l
3.1
2.9
0.22
21
127
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
46
363
1.27
0.83
1.8
1.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
39
301
1.30
0.83
1.1
1.0
u/ml
2.0
2.2
0.10
22
146
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
60
489
1.23
0.82
1.5
1.2
—
—
—
0
0
(3036489) Thrombin time
86
727
1.19
0.82
3.5
2.1
s
21.4
21.0
0.35
69
629
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
65
1.70
0.82
1.4
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
155
1.42
0.81
1.7
1.8
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
22
155
1.42
0.81
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
22
155
1.42
0.81
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
22
155
1.42
0.81
1.1
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
64
773
0.82
0.81
1.4
1.5
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
0
24
0.00
0.79
0.0
1.1
—
1371.8
—
0
16
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
46
574
0.80
0.79
1.4
1.5
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
25
0.00
0.79
0.0
1.0
—
1.5
—
0
16
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
22
156
1.41
0.78
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
22
156
1.41
0.78
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
22
156
1.41
0.78
1.1
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
26
0.00
0.78
0.0
2.1
—
3.1
—
0
10
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
185
1663
1.12
0.78
2.1
2.2
g/l
0.2
0.2
0.43
171
1562
(3014271) Vancomycin [Susceptibility]
12
74
1.62
0.78
3.1
2.9
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
21
148
1.42
0.77
1.3
1.1
titre
70.0
140.0
—
6
29
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
502
4737
1.08
0.76
2.4
2.1
mg/l
2.8
2.9
0.45
443
4033
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
92
790
1.17
0.75
1.1
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
48
592
0.81
0.75
1.4
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
67
1.64
0.75
1.5
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
48
387
1.25
0.74
1.6
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
24
2.09
0.74
1.6
1.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
80
681
1.18
0.73
4.1
6.1
%
1.7
1.6
0.49
73
637
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
125
1.44
0.72
3.3
2.2
e6/l
663.2
787.7
—
9
50
(3007930) Methemoglobin/Hemoglobin.total in Blood
80
682
1.18
0.72
4.2
6.1
%
0.9
0.9
0.00
73
640
(3014133) Dog dander IgE Ab [Units/volume] in Serum
40
317
1.27
0.72
1.1
1.1
u/ml
0.7
4.8
3.28
19
118
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
12
76
1.58
0.71
1.3
1.6
pmol/l
12.5
14.0
0.64
12
63
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
76
1.58
0.71
1.1
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
76
1.58
0.71
1.1
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
40
1.75
0.71
1.1
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
19
134
1.42
0.71
1.1
1.3
nmol/l
43.5
30.6
0.89
14
114
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
5
26
1.93
0.70
1.0
1.5
nmol/l
7.1
464711.1
—
5
17
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
41
327
1.26
0.70
1.2
1.2
u/ml
4.5
5.2
0.14
15
105
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
53
436
1.22
0.70
1.5
1.4
e6/l
24.4
32.6
0.20
41
339
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
53
436
1.22
0.70
1.6
1.5
e6/l
143.7
1603.8
1.48
42
356
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
59
704
0.83
0.68
1.3
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
33
257
1.29
0.68
1.2
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
77
1.56
0.68
1.1
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
26
341
0.76
0.68
2.6
2.4
%
16.3
16.4
0.02
18
170
(40761535) Cells panel - Urine sediment
160
1443
1.12
0.66
3.9
3.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
191
0.68
0.66
2.8
2.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
16
111
1.44
0.66
1.9
1.4
umol/l
18.0
25.1
0.49
16
105
(4034850)
50
603
0.83
0.65
15.6
8.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
69
587
1.18
0.65
1.1
1.1
u/ml
3.3
4.2
0.14
14
83
(3002032) Base excess in Venous blood by calculation
167
1512
1.11
0.65
4.8
3.5
mmol/l
1.5
1.9
0.77
133
1217
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
40
322
1.25
0.65
1.2
1.2
u/ml
4.7
4.6
0.01
19
138
(3015235) Bicarbonate [Moles/volume] in Capillary blood
49
405
1.21
0.63
2.0
2.8
mmol/l
24.4
25.0
0.62
42
354
(3019977) pH of Arterial blood
13
87
1.50
0.63
1.7
3.4
ph
7.4
7.4
—
6
27
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
60
708
0.84
0.63
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
60
707
0.84
0.62
1.3
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
164
0.67
0.61
1.1
1.3
u/ml
0.0
0.7
—
6
65
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
25
191
1.31
0.61
1.3
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
152
1676
0.90
0.61
3.6
3.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
60
509
1.18
0.60
2.7
3.1
u/ml
0.4
0.4
0.08
35
283
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
0
21
0.00
0.60
0.0
1.4
—
5.7
—
0
11
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
38
308
1.24
0.59
1.2
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
52
1.54
0.59
1.1
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
376
3551
1.07
0.58
1.8
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
89
1.46
0.58
1.5
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
43
355
1.22
0.57
1.5
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
86
0.58
0.56
1.6
2.7
ml
2082.8
1951.5
—
5
76
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
40
329
1.22
0.56
2.1
2.5
—
—
—
0
0
(3000012) Reticulocyte production index
5
89
0.56
0.56
1.4
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
91
804
1.14
0.55
6.3
3.7
mmol/l
24.1
24.1
0.10
83
731
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
38
1.58
0.54
1.3
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
9
60
1.50
0.54
3.2
3.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
41
492
0.83
0.54
1.2
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
99
1.42
0.54
2.3
2.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
42
349
1.21
0.54
1.4
1.4
u/ml
102.3
110.4
—
7
61
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
61
1.48
0.53
1.8
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
61
705
0.86
0.52
1.3
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
133
0.68
0.51
1.1
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
83
1.45
0.51
1.6
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
83
1.45
0.51
1.6
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
40
1.50
0.51
1.7
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
126
1.35
0.51
1.6
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
9
64
1.41
0.51
1.1
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
333
3150
1.07
0.50
1.6
1.7
nmol/l
1115.4
1191.4
0.86
244
2400
(3009343) pH of Capillary blood
92
1029
0.89
0.50
3.4
3.4
ph
7.4
7.4
0.83
13
127
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
84
1.43
0.49
1.3
1.1
iu/ml
155.7
190.4
0.36
12
84
(3013290) Carbon dioxide [Partial pressure] in Blood
31
377
0.82
0.48
3.5
3.9
kpa
5.0
5.0
0.31
31
371
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
482
4619
1.05
0.48
2.8
2.9
ng/l
1117.3
1231.0
0.27
388
3864
(3027315) Oxygen [Partial pressure] in Blood
31
376
0.82
0.47
3.5
4.0
kpa
8.9
8.7
0.38
31
370
(3012501) Base excess in Blood by calculation
31
376
0.82
0.47
3.4
3.9
mmol/l
2.8
2.6
0.18
19
255
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
756
7331
1.05
0.47
4.0
3.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
48
1.46
0.46
4.6
4.7
—
—
—
0
0
(3019225) pH of Specimen
163
1762
0.92
0.46
4.6
3.9
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
13
94
1.39
0.46
9.7
6.0
u/ml
56.6
62.2
—
5
22
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
112
1018
1.11
0.45
1.6
1.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
50
1.40
0.45
1.6
3.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
50
1.40
0.45
1.7
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
50
1.40
0.45
1.6
3.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
28
229
1.23
0.44
1.0
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
14
104
1.35
0.43
1.9
1.4
u/l
9.9
13.1
1.64
14
98
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
94
1038
0.90
0.43
3.4
3.4
kpa
5.1
5.2
0.83
85
971
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
31
1.61
0.43
1.4
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
31
1.61
0.43
1.4
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
31
1.61
0.43
1.4
1.0
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
5
31
1.61
0.43
1.2
1.1
—
6.7
—
0
5
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
32
1.56
0.42
1.6
1.3
%
30.2
21.8
—
5
24
(3021447) Carbon dioxide [Partial pressure] in Venous blood
164
1525
1.08
0.42
4.9
3.5
kpa
5.8
5.8
0.04
156
1480
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
11
150
0.73
0.41
1.2
1.1
—
58.7
—
0
15
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
33
1.52
0.41
6.6
2.3
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
190.7
—
0
7
(3010937) Rubella virus Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
16
0.00
0.41
0.0
1.0
—
19.8
—
0
11
(3007566) Smooth muscle Ab [Titer] in Serum
59
520
1.14
0.41
1.3
1.2
titre
77.0
90.2
—
10
40
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
105
1.34
0.41
1.5
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
10.0
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
8
60
1.33
0.40
1.6
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
20
159
1.26
0.40
2.5
2.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
11
149
0.74
0.40
1.2
1.1
—
58.7
—
0
10
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
262
2483
1.06
0.40
1.6
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
411
0.85
0.40
1.2
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
110
1008
1.10
0.39
6.4
7.1
mmol/l
24.5
24.9
0.60
110
1001
(3044927) Protein electrophoresis panel - Urine
12
160
0.75
0.39
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
71
1.41
0.39
1.1
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
16
204
0.78
0.39
1.1
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
215
0.79
0.39
2.9
2.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
90
989
0.91
0.39
3.4
3.5
mmol/l
1.5
1.8
0.39
58
735
(3006922) Hepatitis E virus Ab [Presence] in Serum
16
124
1.29
0.38
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
68
1.32
0.37
1.0
1.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
42
364
1.16
0.37
1.9
3.0
kpa
8.5
8.2
0.55
37
336
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
37
1.35
0.37
1.4
3.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
116
0.69
0.37
1.3
1.2
—
11.1
—
0
13
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
116
0.69
0.37
1.3
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
80
725
1.11
0.37
1.7
1.8
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
9
70
1.29
0.36
4.0
3.8
mg/l
88.2
64.6
—
9
50
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
71
640
1.11
0.36
1.4
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
59
526
1.12
0.36
2.3
2.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
212
0.80
0.35
1.2
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
42
1.43
0.35
1.8
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
79
0.63
0.35
4.4
3.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
126
1355
0.93
0.35
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
77
847
0.91
0.35
1.4
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
67
604
1.11
0.34
2.8
2.4
g/l
3.1
3.1
0.21
56
476
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
44
1.36
0.34
1.0
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
153
1434
1.07
0.34
2.7
2.7
g/l
10.0
10.6
0.91
141
1310
(3002523) Influenza virus A Ag [Presence] in Specimen
31
361
0.86
0.33
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
48
425
1.13
0.33
1.2
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
134
1433
0.93
0.33
3.4
3.8
%
0.5
0.6
0.18
25
306
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
95
1030
0.92
0.33
1.7
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
42
369
1.14
0.32
6.0
5.1
iu/ml
188.1
362.5
—
7
50
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
85
780
1.09
0.32
2.5
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
697
7140
0.97
0.32
2.5
2.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
132
1410
0.93
0.32
3.8
4.1
%
0.0
0.6
0.90
29
323
(3003740) Influenza virus B Ag [Presence] in Specimen
31
359
0.86
0.32
1.2
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
165
1.21
0.31
1.4
1.5
%
36.3
35.4
0.03
12
103
(3023410) Appearance of Cerebral spinal fluid
24
202
1.19
0.31
1.2
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
33
286
1.16
0.31
1.9
2.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
153
0.78
0.30
1.2
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
75
1.33
0.30
1.0
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
33
287
1.15
0.30
2.3
1.9
—
4.2
—
0
6
(3021879) Hepatitis B virus core Ab [Presence] in Serum
169
1599
1.06
0.30
1.6
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
93
1.29
0.30
1.1
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
93
1.29
0.30
1.1
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
93
1.29
0.30
1.1
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
93
1.29
0.30
1.1
1.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
11
141
0.78
0.29
1.2
1.1
—
2.1
—
0
8
(3006184) Hemoglobin [Mass/volume] in Capillary blood
42
373
1.13
0.29
2.1
2.2
g/l
127.9
130.0
0.25
32
279
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
28
241
1.16
0.29
1.3
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
34
387
0.88
0.28
3.1
2.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
16
130
1.23
0.28
1.5
1.3
—
1.5
—
0
7
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
49
440
1.12
0.28
1.3
1.2
u/ml
27.0
42.4
—
6
40
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
13
162
0.80
0.28
1.2
1.2
mg/l
39.6
40.3
0.02
13
135
(4024509)
13
162
0.80
0.28
1.3
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
158
1.20
0.28
1.4
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
46
512
0.90
0.28
1.2
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
8
63
1.27
0.27
1.8
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
43
384
1.12
0.27
1.3
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
21
177
1.19
0.27
1.2
1.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
9
120
0.75
0.27
20.3
13.8
nmol/l
975.4
874.5
—
9
115
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
131
1.22
0.27
1.2
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
311
0.87
0.27
3.4
3.2
nmol/l
0.8
0.8
0.01
19
249
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
77
833
0.92
0.27
2.2
1.7
mg/l
2.7
3.8
0.70
52
586
(3023511) Choriogonadotropin [Units/volume] in Urine
50
552
0.90
0.26
1.5
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
15
182
0.82
0.26
1.0
1.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
24
206
1.17
0.26
1.6
1.6
mmol/l
7.7
7.6
0.06
16
122
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
72
0.69
0.26
2.2
2.3
nmol/l
126.0
150.4
—
5
65
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
73
0.68
0.26
1.0
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
142
1498
0.94
0.25
3.7
4.0
%
0.0
0.1
9.41
33
380
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
51
463
1.10
0.25
1.2
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
120
1272
0.94
0.25
1.8
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
637
1.09
0.25
2.8
2.4
g/l
3.5
3.7
0.68
56
465
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
56
611
0.91
0.24
1.5
1.6
iu/ml
0.0
0.1
—
10
125
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
638
1.08
0.24
2.8
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
69
638
1.08
0.24
2.8
2.4
g/l
7.4
7.4
0.01
58
490
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
133
1.20
0.24
1.2
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
33
293
1.13
0.24
1.3
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
124
1.21
0.24
1.7
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
115
1.22
0.23
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
118
1116
1.06
0.23
2.7
2.5
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
5
38
1.32
0.23
2.0
1.6
mmol/l
1.2
1.2
—
5
38
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
162
1.17
0.23
3.6
3.1
%
59.8
54.9
—
8
115
(4146454)
14
168
0.83
0.22
3.0
2.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
32
358
0.89
0.22
3.4
3.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
95
0.74
0.22
1.7
2.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
27
305
0.88
0.22
1.6
2.2
umol/l
4.4
4.6
0.07
22
221
(3000330) Specific gravity of Urine by Test strip
87
926
0.94
0.22
3.4
3.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
22
191
1.15
0.22
1.5
1.2
u/l
43.3
54.2
0.72
12
135
(3050129) First trimester maternal screen panel - Serum or Plasma
94
885
1.06
0.21
1.4
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
28
248
1.13
0.21
1.2
1.3
—
70.5
—
0
13
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(4038314)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
11.7
—
0
12
(3007700) Barley IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
0.1
—
0
7
(3022475) Manganese [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
12
98
1.23
0.21
1.7
1.4
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
55
595
0.92
0.21
3.3
3.7
mmol/l
1.2
1.4
0.66
55
587
(4015189)
5
43
1.16
0.21
1.2
2.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
89
1.24
0.21
1.5
1.9
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
11
89
1.24
0.21
1.1
1.1
miu/ml
1443.3
1640.7
0.23
11
89
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
6
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
10.9
—
0
13
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013512) EKG study
516
5052
1.03
0.21
3.5
3.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
14
117
1.20
0.20
1.5
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
132
1259
1.05
0.20
3.7
2.9
kpa
4.7
4.6
0.22
125
1219
(3018001) Oat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.1
—
0
5
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
13
155
0.84
0.20
1.2
1.4
umol/l
9.8
11.6
0.53
13
146
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
13
155
0.84
0.20
1.2
1.1
mg/l
271.6
244.2
0.17
13
134
(4133840)
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
50
461
1.09
0.20
3.0
2.0
—
—
—
0
0
(3024471) HLA-A [Type]
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
99
1.21
0.19
1.1
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
42
385
1.09
0.19
3.2
3.7
%
56.3
57.2
0.23
42
385
(3020891) Body temperature
69
647
1.07
0.19
3.6
4.5
—
—
—
0
0
(4306422)
35
318
1.10
0.18
1.1
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
10
81
1.24
0.18
1.0
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
518
5081
1.03
0.18
4.6
3.8
estimate
0.0
0.0
1.28
165
1774
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
31
280
1.11
0.18
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
60
1.17
0.17
1.3
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
151
1569
0.96
0.17
3.5
4.0
%
0.7
0.9
0.48
37
415
(3042111) Morphology [Interpretation] in Bone marrow Narrative
30
272
1.10
0.17
1.5
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
67
0.75
0.17
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
67
0.75
0.17
1.2
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
33
301
1.10
0.17
1.6
1.3
mmol/l
62.1
64.6
0.13
26
246
(3016650) Hepatitis A virus Ab [Presence] in Serum
36
330
1.09
0.17
1.2
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
44
408
1.08
0.16
2.8
2.4
ug/min
49.2
93.0
1.23
30
253
(3051611) Lipemic interference index of Serum or Plasma
21
187
1.12
0.15
1.9
3.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
19
168
1.13
0.15
1.4
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
168
1.13
0.15
1.0
1.0
—
—
—
0
0
(4281824)
25
226
1.11
0.15
1.2
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
14
121
1.16
0.15
1.0
1.0
u/ml
0.1
4.6
—
5
18
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
129
0.85
0.14
2.3
2.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
294
1.09
0.14
1.4
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
46
431
1.07
0.14
1.2
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
17
151
1.13
0.13
1.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
108
0.83
0.13
1.1
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
40
374
1.07
0.13
3.3
3.4
e9/l
4.1
4.1
0.09
40
374
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
345
1.07
0.12
1.7
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
672
6643
1.02
0.12
3.3
3.4
ng/l
23.5
45.4
2.49
389
4182
(40760888) Immunoglobulin light chains.free panel - Serum
39
365
1.07
0.12
2.6
3.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
179
0.89
0.12
1.4
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
80
767
1.04
0.12
4.1
2.5
%
1.4
1.2
0.37
80
762
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
220
0.91
0.12
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
207
2118
0.98
0.11
1.4
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
199
0.90
0.11
1.4
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
233
2281
1.02
0.11
1.4
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
12
136
0.88
0.11
1.1
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
134
1.12
0.11
1.4
1.7
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
28
301
0.93
0.10
1.5
1.4
mmol/l
7.1
7.3
0.14
21
214
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
231
1.08
0.10
1.2
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
38
403
0.94
0.10
1.4
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
177
0.90
0.10
1.1
1.4
e6/l
23578.0
115318.7
—
9
120
(44813793)
17
154
1.10
0.10
1.1
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
86
890
0.97
0.10
2.0
2.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
487
1.05
0.09
3.0
3.6
mg/l
153.0
68.2
0.42
37
401
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
233
1.07
0.09
1.2
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
22
237
0.93
0.09
1.4
1.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
65
626
1.04
0.09
2.7
2.7
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
489
1.04
0.08
3.0
3.6
mg/l
28.1
75.4
1.04
37
404
(3029075) Extractable nuclear Ab panel - Serum
5
61
0.82
0.08
1.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
61
0.82
0.08
1.0
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
34
322
1.06
0.08
1.2
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
85
825
1.03
0.08
1.9
2.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
25
234
1.07
0.08
1.2
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
65
1.08
0.08
1.4
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
127
1.10
0.08
1.1
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
307
0.94
0.07
1.1
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
71
0.84
0.07
1.0
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
74
0.81
0.07
1.5
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
46
441
1.04
0.07
1.3
1.7
e6/l
22661.3
11661.0
0.31
31
323
(40765089) Chromosome analysis panel - Blood by G-banded
6
75
0.80
0.07
1.0
1.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
589
1.04
0.07
2.9
2.4
g/l
10.9
10.3
0.36
56
505
(3020630) Protein [Mass/volume] in Serum or Plasma
138
1352
1.02
0.07
2.8
2.7
g/l
67.4
66.7
0.61
129
1235
(3036071) Salmonella sp Ab [Titer] in Serum
8
77
1.04
0.07
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
81
0.86
0.07
1.1
1.7
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
80
0.87
0.07
1.1
1.5
—
769331.3
—
0
8
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
82
0.85
0.07
1.1
2.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
84
0.83
0.07
1.6
1.8
—
—
—
0
0
(4198724)
7
84
0.83
0.07
3.0
1.9
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
90
0.89
0.06
1.1
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
92
0.87
0.06
1.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
92
0.87
0.06
1.0
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
39
407
0.96
0.06
1.4
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
64
621
1.03
0.06
1.9
2.0
ug/l
1.0
1.7
0.60
54
542
(3051651) Icteric interference index of Serum or Plasma
13
119
1.09
0.06
2.1
3.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
86
880
0.98
0.06
2.0
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
62
603
1.03
0.05
3.1
3.3
g/l
0.2
0.3
0.44
31
240
(3017704) Immunofixation for Urine
10
90
1.11
0.05
1.1
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
139
1.08
0.05
1.5
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
34
327
1.04
0.05
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
20
189
1.06
0.04
1.1
1.6
—
—
—
0
0
(4027681)
12
130
0.92
0.04
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
569
5721
0.99
0.04
1.5
1.5
—
—
—
0
0
(44806118)
22
209
1.05
0.04
1.3
1.5
—
—
—
0
0
(44790047)
22
209
1.05
0.04
1.3
1.5
—
—
—
0
0
(44790049)
22
209
1.05
0.04
1.3
1.5
—
—
—
0
0
(44790048)
22
209
1.05
0.04
1.3
1.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
29
302
0.96
0.04
1.0
1.1
iu/ml
82.8
1804.4
—
5
74
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
192
1900
1.01
0.04
1.8
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
38
368
1.03
0.04
1.5
2.1
nmol/l
0.7
0.9
0.91
32
305
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
11
119
0.92
0.04
1.4
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
24
230
1.04
0.03
1.2
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
24
230
1.04
0.03
1.2
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
34
351
0.97
0.03
2.5
3.1
umol/l
30.2
34.7
0.79
26
298
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
237
2389
0.99
0.03
1.6
1.8
%
1.4
1.4
0.60
205
2120
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
52
508
1.02
0.03
1.5
1.5
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
10
92
1.09
0.03
1.3
1.1
u/l
99.3
85.2
—
10
74
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
67
658
1.02
0.03
1.7
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
33
320
1.03
0.03
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
52
509
1.02
0.03
1.9
1.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20
209
0.96
0.03
1.1
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
530
5281
1.00
0.02
3.1
3.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
142
1.06
0.02
1.5
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
158
0.95
0.02
1.1
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
158
0.95
0.02
1.1
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
158
0.95
0.02
1.1
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
20
192
1.04
0.02
1.2
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
228
0.96
0.02
1.1
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
24
232
1.03
0.02
1.2
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
10
93
1.08
0.02
1.3
1.1
u/l
39.5
23.1
—
10
71
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
11
103
1.07
0.02
1.0
1.0
ng/l
678.4
704.6
—
5
69
(3015183) Erythrocyte sedimentation rate
11
117
0.94
0.01
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
69
699
0.99
0.01
2.1
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
89
899
0.99
0.01
1.9
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
18
173
1.04
0.01
1.1
1.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
53
523
1.01
0.01
1.4
1.4
ug/g
315.5
297.1
0.23
29
282
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
11
104
1.06
0.01
1.0
1.0
ng/l
343.0
320.1
—
5
71
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12
126
0.95
0.00
1.3
1.1
u/l
0.9
1.1
—
7
63
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
156
0.96
0.00
4.0
2.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
19
184
1.03
0.00
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
33
336
0.98
0.00
1.5
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
60
594
1.01
0.00
1.7
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
89
896
0.99
0.00
1.9
2.0
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
10
95
1.05
0.00
1.6
1.2
u/l
14.6
10.5
—
10
84
(3006653) Thiamine [Moles/volume] in Blood
11
105
1.05
0.00
1.2
1.4
nmol/l
149.9
136.0
0.67
11
105
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
15
145
1.03
0.00
1.3
1.6
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
15
155
0.97
0.00
1.0
1.1
nmol/l
422.1
399.9
0.18
15
141
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
14
139
1.01
0.00
1.2
2.0
mg/l
3.5
3.8
0.16
14
132
(40768806) Pleura Pathology biopsy report
15
151
0.99
0.00
1.4
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
22
219
1.00
0.00
1.5
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
26
261
1.00
0.00
3.7
3.4
%
1.8
1.3
0.25
18
213
(3048929) Epstein Barr virus Ab [Presence] in Serum
68
675
1.01
0.00
1.4
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
11
106
1.04
0.00
1.0
1.0
ng/l
51.2
46.6
—
5
69
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
116
1.03
0.00
1.1
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
19
194
0.98
0.00
1.3
2.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
38
384
0.99
0.00
1.4
1.2
u/ml
201.0
260.1
0.96
22
246
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
40
404
0.99
0.00
1.2
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
122
0.98
0.00
1.5
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
53
526
1.01
0.00
1.3
1.2
u/ml
2.2
2.3
—
5
59
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
53
534
0.99
0.00
1.2
1.2
u/ml
2.6
9.1
—
6
96
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
64
636
1.01
0.00
1.8
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
22
222
0.99
0.00
2.1
3.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
337
1.01
0.00
1.7
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
136
1357
1.00
0.00
3.0
2.8
e9/l
4.0
4.1
0.16
110
1090
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
117
1.03
0.00
1.1
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
133
0.98
0.00
1.2
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
173
0.98
0.00
1.7
1.8
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
22
223
0.99
0.00
1.3
1.6
%
58.6
57.8
0.02
11
147
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
24
237
1.01
0.00
2.9
2.4
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
30.8
—
0
5
(3017569) Oxygen content in Arterial blood
8
81
0.99
0.00
1.6
2.7
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
5.0
—
402.8
—
0
5
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
116.0
—
0
5
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
5
49
1.02
0.00
2.0
1.1
pmol/l
338.2
299.1
—
5
36
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(40758358) Immune stain study
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
55
550
1.00
0.00
1.1
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
130
1.00
0.00
1.5
1.4
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
76
0.92
0.00
2.0
2.5
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
19
190
1.00
0.00
6.8
3.7
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
88
0.91
0.00
1.1
1.3
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
90
1.00
0.00
1.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
140
1.00
0.00
1.1
1.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
99
0.91
0.00
2.2
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
13
130
1.00
0.00
1.1
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
69
1.01
0.00
1.1
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
5
56
0.89
0.00
1.2
1.3
%
47.3
48.7
—
5
50
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.5
—
0
6
(3013862) HLA-DP [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
64.8
—
0
6
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
8
0.00
0.00
0.0
1.0
—
7.8
—
0
8
(46236302) HLA-C [Type] by High resolution typing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
1234.0
—
0
6
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
7
0.00
0.00
0.0
1.0
—
3.1
—
0
7
(3004959) Base excess in Arterial cord blood by calculation
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
7
79
0.89
0.00
1.0
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
9
91
0.99
0.00
1.7
2.0
ug/l
1.2
2.3
—
9
76
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
66
0.91
0.00
1.2
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint CD2_BENIGN_MELANOCYTIC_FACE and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_MELANOCYTIC_FACE 0.859 [0.77, 0.96] 0.009
Birth year 0.997 [0.99, 1.01] 0.513

During the follow-up period (1.1.1998 — 31.12.2019), 755 out of 8978 females with CD2_BENIGN_MELANOCYTIC_FACE died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_MELANOCYTIC_FACE 0.856 [0.76, 0.97] 0.013
Birth year 0.993 [0.98, 1.0] 0.108

During the follow-up period (1.1.1998 — 31.12.2019), 590 out of 4616 males with CD2_BENIGN_MELANOCYTIC_FACE died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_MELANOCYTIC_FACE.

N-year risk Females Males
1 0.072% 0.191%
5 0.436% 1.109%
10 1.176% 2.921%
15 2.395% 5.773%
20 4.597% 9.912%

Relationships between endpoints

Index endpoint: CD2_BENIGN_MELANOCYTIC_FACE – Melanocytic naevi of other and unspecified parts of face

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data